LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 22.10%1.1B | 42.00%403M | 27.78%286.1M | 30.25%231.2M | -17.25%176M | 78.79%897.9M | 73.58%283.8M | -12.78%223.9M | 34.27%177.5M | 523.71%212.7M |
Net income from continuing operations | 48.73%-311.1M | -183.07%-219.1M | 40.72%-183.7M | 2.88%64.3M | 109.72%27.4M | 44.96%-606.8M | 86.97%-77.4M | -170.18%-309.9M | 154.11%62.5M | -1.44%-282M |
Operating gains losses | -133.24%-70.8M | 231.72%100.5M | -40.51%172.7M | 46.60%-102.1M | -227.18%-241.9M | -49.08%213M | -131.99%-76.3M | 240.33%290.3M | -382.01%-191.2M | 612.36%190.2M |
Depreciation and amortization | 9.51%1.53B | -0.05%405.4M | 13.91%388.2M | 12.80%374.5M | 13.60%357.4M | 12.56%1.39B | -25.88%405.6M | 45.70%340.8M | 41.46%332M | 41.84%314.6M |
Deferred tax | -61.42%-171.1M | -76.30%-23.8M | -104.31%-75.8M | -118.72%-47.9M | 29.55%-23.6M | 58.17%-106M | 83.64%-13.5M | 17.37%-37.1M | 42.82%-21.9M | 61.80%-33.5M |
Other non cash items | 47.76%586.6M | 42.52%133.4M | 51.95%124.9M | -9.91%118.2M | 133.44%210.1M | -24.31%397M | 21.56%93.6M | -4.20%82.2M | 40.32%131.2M | -66.44%90M |
Change In working capital | 1.84%-85.5M | 274.43%115.7M | 44.86%-40.8M | -817.17%-90.8M | -104.11%-69.6M | -512.80%-87.1M | -57.38%30.9M | -337.94%-74M | 65.26%-9.9M | 36.85%-34.1M |
-Change in receivables | -60.14%-221M | 2,278.00%108.9M | 19.78%-111.5M | ---- | -133.17%-20.2M | -123.30%-138M | 92.48%-5M | -1,610.87%-139M | ---- | --60.9M |
-Change in prepaid assets | -11.16%-24.9M | 301.75%11.5M | 20.45%5.3M | ---- | -229.17%-7.9M | -4,380.00%-22.4M | -133.14%-5.7M | -43.59%4.4M | ---- | ---2.4M |
-Change in payables and accrued expense | 118.83%160.4M | -111.30%-4.7M | 7.92%65.4M | ---- | 55.18%-41.5M | -12.11%73.3M | -65.85%41.6M | 329.79%60.6M | ---- | ---92.6M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 22.10%1.1B | 42.00%403M | 27.78%286.1M | 30.25%231.2M | -17.25%176M | 78.79%897.9M | 73.58%283.8M | -12.78%223.9M | 34.27%177.5M | 523.71%212.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 35.46%-1.73B | 64.43%-404.3M | 70.47%-334.7M | -263.41%-804.6M | 2.66%-190.6M | 38.27%-2.69B | 60.72%-1.14B | -971.27%-1.13B | -72.83%-221.4M | 84.03%-195.8M |
Net PPE purchase and sale | -20.53%-780.1M | -3.44%-237.3M | -56.35%-210.6M | 15.02%-129M | -54.76%-203.2M | -51.11%-647.2M | -87.11%-229.4M | -57.18%-134.7M | -26.71%-151.8M | -31.17%-131.3M |
Net business purchase and sale | 42.68%-1.32B | 79.68%-202.5M | 87.59%-136.5M | -566.59%-899.9M | -16.11%-79.3M | 41.65%-2.3B | 64.11%-996.5M | -4,098.09%-1.1B | -997.56%-135M | 93.93%-68.3M |
Net other investing changes | 40.20%364.1M | -60.25%35.5M | -87.75%12.4M | 242.97%224.3M | 2,318.42%91.9M | 1,523.13%259.7M | 1,523.64%89.3M | 1,559.02%101.2M | 1,535.00%65.4M | 850.00%3.8M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 35.46%-1.73B | 64.43%-404.3M | 70.47%-334.7M | -263.41%-804.6M | 2.66%-190.6M | 38.27%-2.69B | 60.72%-1.14B | -971.27%-1.13B | -72.83%-221.4M | 84.03%-195.8M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -71.04%569M | -49.45%-150.5M | -96.10%67.7M | 75.86%632.2M | 168.29%19.6M | -41.15%1.96B | -110.34%-100.7M | 84.12%1.73B | -45.73%359.5M | -103.78%-28.7M |
Net issuance payments of debt | -63.29%610.9M | 69.82%-139.4M | -95.64%76.7M | 71.87%639M | 696.55%34.6M | 202.40%1.66B | -297.06%-461.9M | 81.20%1.76B | -44.72%371.8M | 99.83%-5.8M |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | -92.62%372.5M | ---- | ---- | ---- | ---- |
Cash dividends paid | -15.64%-20.7M | -16.67%-5.6M | -22.73%-5.4M | -11.11%-5M | -11.90%-4.7M | -36.64%-17.9M | -9.09%-4.8M | 49.43%-4.4M | ---4.5M | ---4.2M |
Net other financing activities | 60.89%-21.2M | 15.38%-5.5M | 83.02%-3.6M | 76.92%-1.8M | 44.92%-10.3M | 24.83%-54.2M | 84.15%-6.5M | -2.91%-21.2M | 23.53%-7.8M | -6,133.33%-18.7M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -71.04%569M | -49.45%-150.5M | -96.10%67.7M | 75.86%632.2M | 168.29%19.6M | -41.15%1.96B | -110.34%-100.7M | 84.12%1.73B | -45.73%359.5M | -103.78%-28.7M |
Net cash flow | ||||||||||
Beginning cash position | 600.00%190.4M | -79.35%237.4M | -25.71%230.6M | 1,605.41%189.3M | 600.00%190.4M | -95.27%27.2M | -36.74%1.15B | -57.12%310.4M | -87.86%11.1M | -95.27%27.2M |
Current changes in cash | -139.28%-68.9M | 84.08%-151.8M | -97.69%19.1M | -81.37%58.8M | 142.37%5M | 134.19%175.4M | 45.71%-953.5M | -24.51%825.1M | -52.65%315.6M | 97.71%-11.8M |
Effect of exchange rate changes | -222.95%-39.4M | 37.50%-3.5M | -187.86%-12.3M | -7.36%-17.5M | -41.86%-6.1M | 64.74%-12.2M | 83.43%-5.6M | 4,566.67%14M | 52.06%-16.3M | -113.07%-4.3M |
End cash Position | -56.88%82.1M | -56.88%82.1M | -79.35%237.4M | -25.71%230.6M | 1,605.41%189.3M | 600.00%190.4M | 600.00%190.4M | -36.74%1.15B | -57.12%310.4M | -87.86%11.1M |
Free cash flow | 26.13%316.2M | 204.60%165.7M | -15.36%75.5M | 297.67%102.2M | -133.42%-27.2M | 239.24%250.7M | 33.01%54.4M | -47.84%89.2M | 107.26%25.7M | 154.16%81.4M |
Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |